Acute and Sub-acute toxicity studies of a herbal formulation Kadukkai chooranam

  • Mohanapriya M PG Scholar, Department of Maruthuvam, Government Siddha Medical College, Arumbakkam, Chennai - 106
  • Kanakavalli K Director General, Central Council for Research in Siddha, Arumbakkam, Chennai - 106
  • Parthibhan P Joint Director, Directorate of Indian Medicine & Homeopathy, Arumbakkam, Chennai -106
DOI: https://doi.org/10.124583/jrbms.v2i4.50
Keywords: Acute toxicity, Kadukkai chooranam, Terminalia chebula, OECD

Abstract

Introduction:

Kadukkai chooranam is an effective drug composition from siddha medicine used for the management of Menorrhagia/Dysfunctional Uterine bleeding (Pitha perumbaadu) which is referenced from a classical age-old text Agathiyar attavanai vaagadam.

Aim of this study

The aim of study was to assess the acute and sub-acute toxicity of the polyherbal composition kadukkai chooranam.

Methodology:

In the acute toxicity study, a single dose of 2000 mg/kg was administered to wistar albino female rat (200-220g) after the proper acclimatization and fasting procedures was made as per the OECD 423 – acute toxicity guidelines. All the animals were observed for physical symptoms and behavioral changes for first 72 h.  In sub-acute toxicity study repeated doses of the polyherbal composition was administered to Wistar albino rats of both genders, separately acclimatized for 7 days and fasted as per OECD -407 guidelines. The animals received two doses of drug (100 mg/kg/day and 200 mg/kg/day) for a period of 28 days. On 28th day of experiment, blood sampling of animals was done for hematological and biochemical analysis i.e. liver and renal function parameters, lipid profile and then sacrificed for histopathological

study of liver and kidney. The rats were observed daily during the period of study, and sacrificed on the 29th day. Observation parameters of the animals included a comparative evaluation of general appearance/behaviour, morbidity/mortality, body weights, haematology, biochemistry, lipid profile and histopathology of major organs of treated and control groups.

Results

 There was no morbidity and mortality noticed with single dose administration in acute toxicity study in wistar rats. In sub-acute toxicity study, no morphological changes were observed in kidney, liver and spleen of animals at dose of 100 mg/kg/day and 200 mg/kg/day.

Conclusions

The results of the present study show that oral administration of kadukkai chooranam did not produce any severe toxic effects in both acute and sub-acute studies in Wistar rats. Therefore, usage of an appropriate dosage will be preferable and considered as safe.

 

References

1. OECD (2002), Test No. 423: Acute Oral toxicity - Acute Toxic Class Method, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264071001-en.
2. OECD (2008), Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264070684-en
3. Baars, E.W., and Hamre, H.J. (2017). Whole Medical Systems versus the System of Conventional Biomedicine: A Critical, Narrative Review of Similarities, Differences, and Factors That Promote the Integration Process. Evid.-Based Complement. Altern. Med. ECAM 2017, 4904930.
4. Breeher, L., Mikulski, M.A., Czeczok, T., Leinenkugel, K., and Fuortes, L.J. (2015). A cluster of lead poisoning among consumers of Ayurvedic medicine. Int. J. Occup. Environ. Health 21, 303–307.
5. Ghane, T., Zamani, N., Hassanian-Moghaddam, H., Beyrami, A., and Noroozi, A. (2018). Lead poisoning outbreak among opium users in the Islamic Republic of Iran, 2016-2017. Bull. World Health Organ. 96, 165–172.
6. Gunturu, K.S., Nagarajan, P., McPhedran, P., Goodman, T.R., Hodsdon, M.E., and Strout, M.P. (2011). Ayurvedic herbal medicine and lead poisoning. J. Hematol. Oncol.J Hematol Oncol 4, 51.
7. Mikulski, M.A., Wichman, M.D., Simmons, D.L., Pham, A.N., Clottey, V., and Fuortes, L.J. (2017). Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation. Int. J. Occup. Environ. Health 23, 187–192.
8. Prakash, S., Hernandez, G.T., Dujaili, I., and Bhalla, V. (2009). Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease. Nat. Rev. Nephrol. 5, 297–300.
9. Sathasivampillai, S.V., Rajamanoharan, P.R.S., Munday, M., and Heinrich, M. (2017). Plants used to treat diabetes in Sri Lankan Siddha Medicine - An ethnopharmacological review of historical and modern sources. J. Ethnopharmacol. 198, 531–599.
10. Subbarayappa, B.V. (1997). Siddha medicine: an overview. Lancet Lond. Engl. 350, 1841–1844.
11. Ying, X.-L., Markowitz, M., and Yan, C.-H. (2018). Folk prescription for treating rhinitis as a rare cause of childhood lead poisoning: a case series. BMC Pediatr. 18, 219.
Published
2019-12-09
How to Cite
1.
Mohanapriya M, Kanakavalli K, Parthibhan P. Acute and Sub-acute toxicity studies of a herbal formulation Kadukkai chooranam. J Res Bio Med Sci [Internet]. 2019Dec.9 [cited 2025Oct.30];2(4):96-102. Available from: http://biosci.in/index.php/jrbms/article/view/50
Issue
Vol 2 No 4 (2019): Oct-Dec
Section
Articles

Copyright and Licensing

For all articles published inJRBMS journal, copyright is retained by the authors. Articles are licensed under an open access Creative Commons CC BY 4.0 licenses, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work, while ensuring that the authors receive proper credit.

In exceptional circumstances articles may be licensed differently. If you have specific condition (such as one linked to funding) that does not allow this license, please mention this to the editorial office of the journal at submission. Exceptions will be granted at the discretion of the publisher.

Reproducing Published Material from other Publishers

It is absolutely essential that authors obtain permission to reproduce any published material (figures, schemes, tables or any extract of a text) which does not fall into the public domain, or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

Permission is required for:

  1. Your own works published by other Publishers and for which you did not retain copyright.
  2. Substantial extracts from anyones' works or a series of works.
  3. Use of Tables, Graphs, Charts, Schemes and Artworks if they are unaltered or slightly modified.
  4. Photographs for which you do not hold copyright.

Permission is not required for:

  1. Reconstruction of your own table with data already published elsewhere. Please notice that in this case you must cite the source of the data in the form of either "Data from..." or "Adapted from...".
  2. Reasonably short quotes are considered fair use and therefore do not require permission.
  3. Graphs, Charts, Schemes and Artworks that are completely redrawn by the authors and significantly changed beyond recognition do not require permission.

Obtaining Permission

In order to avoid unnecessary delays in the publication process, you should start obtaining permissions as early as possible. If in any doubt about the copyright, apply for permission. IJRPHR cannot publish material from other publications without permission.

The copyright holder may give you instructions on the form of acknowledgment to be followed; otherwise follow the style: "Reproduced with permission from [author], [book/journal title]; published by [publisher], [year].' at the end of the caption of the Table, Figure or Scheme.